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Abstract: In implantable materials, surface topography and chemistry are the most important in the
effective osseointegration and interaction with drug molecules. Therefore, structural and surface
modifications of nanostructured titanium dioxide (TiO2) layers are reported in the present work.
In particular, the modification of annealed TiO2 samples with —OH groups and silane derivatives,
confirmed by X-ray photoelectron spectroscopy, is shown. Moreover, the ibuprofen release process
was studied regarding the desorption-desorption-diffusion (DDD) kinetic model. The results proved
that the most significant impact on the release profile is annealing, and further surface modifications
did not change its kinetics. Additionally, the cell adhesion and proliferation were examined based
on the MTS test and immunofluorescent staining. The obtained data showed that the proposed
changes in the surface chemistry enhance the samples’ hydrophilicity. Moreover, improvements in
the adhesion and proliferation of the MG-63 cells were observed.
Keywords: titanium dioxide layers; surface modification; silane derivatives; heat treatment;
cell response
1. Introduction
Modern medicine greatly depends on medical implants applied to support or replace
damaged organs or tissues. They are made of one or more biomaterials, which have to be
biologically indifferent and non-toxic, and not cause inflammatory reactions or produce
harmful substances, but must improve the interaction between the implant surface and
surrounding tissues [1]. What is more, their shape and mechanical properties should
be suitable for the implantation site [1]. Some of the most commonly used materials
for endoprostheses are titanium (Ti) and its alloys because of their excellent mechanical
and biological properties and corrosion resistance [1–4]. However, their implantation is
associated with a long-term integration process with tissues, leading to side effects such
as inflammation and even implant recoil [1,5]. Therefore, it is necessary to modify their
surfaces to improve the processes of osseointegration [1,5,6]. A stable and porous layer
that firmly adheres to the substrate, such as titanium dioxide obtained by the anodization
process, is one such modification [1,5].
Anodic TiO2 (ATO) layers can be further modified to improve the biomaterial interac-
tion with the cells and alter the drug release process. Amorphous TiO2 can be functionalized
with sodium hydroxide (NaOH) [7–11], which results in better hydrophilicity of the sur-
faces, and thus, improvements in the adsorption of water and protein molecules, and
consequently, the cell adhesion [7,12]. Another way of modifying the samples is coating
them with self-assembled monolayers (SAMs), i.e., coatings resulting from the adsorp-
tion of organic molecules from a solution [13]. Due to hydroxyl groups (-OH) on the
Molecules 2021, 26, 1723. https://doi.org/10.3390/molecules26061723 https://www.mdpi.com/journal/molecules
Molecules 2021, 26, 1723 2 of 16
TiO2 surface, it is possible to form chemical bonds between them and organic monolay-
ers [13]. Some such compounds are silane derivatives, which possess different functional
groups, such as amino (-NH2), thiol (-SH), carboxyl (-COOH), and glycidyl (-CH-(O)-CH2)
groups [13–15]. Their presence can considerably increase drug delivery control—e.g., take
ibuprofen [16]—and improve interactions with cells, e.g., fibroblasts [17]. What is more,
their adsorption on the TiO2 surface is almost irreversible [18] and alters the wettability of
the samples [19].
To enhance the biomaterial’s biocompatibility, we can also modify its surface and
crystalline structure. The as-prepared anodic TiO2 layers are amorphous [1,20,21]; however,
simple annealing of the materials at the appropriate temperature leads to a phase transition
to anatase, rutile, or mixed phases [1,20–22]. The thermal treatment of anodic nanostruc-
tures also leads to decreased fluorine content, which may play a role in the interaction
between the biomaterial and cells [20,23]. Among all forms, anatase possesses the best
antibacterial properties [24] and may impact drug release from ATO layers [25].
As shown in our previous articles [11,25,26], anodic nanoporous TiO2 layers with dif-
ferent crystalline structures can be used as potential drug delivery systems for compounds
with varied structures and water solubility. Typically, the release profiles of, e.g., ibuprofen
and gentamicin from amorphous ATO layers, are characterized by a burst release stage,
followed by continuous delivery of the medicine [11,25,26]. There are many possibilities for
suppressing the initial burst effect, among which changing the crystalline structure [25,26]
and functionalization of the TiO2 surface [11,27–29] are the most commonly exploited.
Biomaterials have to provide rapid and robust connections with the surrounding
tissues to avoid implant rejection [30]. The initial interaction between cells and a biomaterial
surface plays a crucial role in cell adhesion, spreading, migration, proliferation, and
differentiation [7,31–34]. Within the first seconds in the in vitro or in vivo conditions, the
adsorption of water and proteins from the cellular medium or body fluids occurs [30,35].
This process is affected by surface properties, such as wettability, surface energy, crystalline
structure, electrical properties, and the presence of nano- or microstructures or functional
groups [30,33,36,37]. The advantage of nanostructured surfaces over the flat titanium
sample is due to the increased surface roughness at the nanoscale level, which is combined
with locally increased charge density at the surface irregularities, which promotes protein
adsorption [36,37]. What is more, the protein adsorption is followed by the interaction
between cells and implant surface using the van der Waals forces [4]. Later, bonds between
the cell surface receptors (integrins) and extracellular matrix proteins are formed [4,12,30],
which further leads to the regulations of the cell functions [12]. Then, the cell’s cytoskeleton
is reorganized to form filopodia and finger-shaped projections, making it possible to move
across the implant surface [4,30]. As mentioned above, the functionalization of the TiO2
surface can cause differences in cell behavior on the examined samples. For example,
NaOH-modified layers exhibit increased hydrophilicity and surface roughness that should
improve the biomaterial cell response, but the release of sodium ions may deteriorate cell
adhesion and proliferation [7]. Additionally, the presence of silane derivative monolayers
on TiO2 layers affects cell behavior [12,17]. For instance, 3T3 fibroblasts adhere better to
the samples modified with (3-aminopropyl)trimethoxysilane than those modified with
(3-mercaptopropyl)trimethoxysilane [17].
Although it was proven that the change in the crystalline structure of TiO2 influences
the drug delivery process, the cell response to anatase or rutile was inconclusive [38–40].
Some studies confirmed the improvements in the adhesion and proliferation of cells
regarding the annealed ATO samples compared with amorphous ones [39], while oth-
ers demonstrated an adverse effect of fluoride ions regarding cell proliferation [38,40].
Nonetheless, the anatase phase’s enhanced impact on the cell response may be attributed
to a better wettability of annealed TiO2 layers [40].
Considering the above, the impact of the annealing process on modifying ATO samples
with NaOH was studied. Moreover, the effects of the further functionalization of such
layers with different silane derivatives (i.e., (3-aminopropyl)triethoxysilane (APTES), (3-
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glycidyloxypropyl)trimethoxysilane (GPTMS), and (3-mercaptopropyl)trimethoxysilane
(MPTMS)) on the ibuprofen delivery process and MG-63 cells response were examined.
Complex research on the influences of functionalization of annealed TiO2 layers on the
interactions with osteoblast-like cells and drug molecules has not yet been presented to the
best of our knowledge.
2. Results and Discussion
2.1. The Effect of the Crystalline Structure on the ATO Modification with NaOH
The literature shows that annealed titania samples exhibit better bioactivity and
interaction with osteoblastic cells [38,40,41]. While most articles have been focused mainly
on the modification of amorphous ATO samples [9,10], we have decided to examine the
influence of the annealing process on the effectiveness of the modification of titanium
dioxide layers with NaOH. Based on our previous study [20], two annealing temperatures
(400 and 600 ◦C) were selected for obtaining the anatase and mixed anatase and rutile
phases without destruction of the nanoporous structure. For successful modification of
TiO2 layers, two approaches were applied—i.e., (i) the samples were annealed prior the
immersion in NaOH; (ii) the amorphous NaOH-modified samples were annealed at the
temperatures of 400 or 600 ◦C. The SEM micrographs of the samples modified according to
the procedure (i) are shown in Figure 1.
Figure 1. FE-SEM images of nanoporous TiO2 layers non-modified (a,b,e) and modified with 0.5 M (c,f) or 1.0 M (d,g)
NaOH for 15 min. The TiO2 layers were non-annealed (a) and annealed at 400 (b–d) or 600 ◦C (e–g) for 2 h before the
surface modification with NaOH.
Based on FE-SEM images for the annealed TiO2 layers (Figure 1), it can be stated
that, contrary to the amorphous anodic TiO2 [11], soaking in NaOH solution did not
lead to any significant change in the surface morphology. Moreover, even when a more
concentrated sodium hydroxide solution (Figure 1d,g) was used, the surface morphology
did not change like it did for the amorphous layers [11]. Figure S1 and Table S1 show the
chemical composition of studied TiO2 layers based on the EDS analyses. In general, the
EDS spectra of ATO layers showed only Ti and O peaks, and the calculated amounts of
sodium and fluorine were both equal to 0 within the margin of error. It indicates that the
annealed TiO2 samples cannot be modified effectively with sodium hydroxide using the
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proposed experimental procedure, which is in contradiction to the research conducted by
Morgado et al. [42], where titanate nanotubes were formed by hydrothermal treatment of
an anatase powder with a concentrated NaOH solution (10 M) at moderate temperatures
(90–170 ◦C). Therefore, it can be concluded that the surface modification of annealed
TiO2 layers can be effective only at higher NaOH concentrations and temperatures, and
extended modification times. However, as we have previously demonstrated, the NaOH
concentration increase may result in the deterioration of TiO2 nanoporosity [11], which is
a disadvantage. Therefore, the modification sequence was changed so that the annealing
process was conducted after the modification with NaOH. FE-SEM images of the obtained
nanostructures are presented in Figure 2.
Figure 2. Microphotographs from the FE-SEM of ATO layers modified with 0.5 M (a,c) or 1.0 M (b,d) NaOH for 15 min. The
TiO2 layers were annealed at 400 (a,b) or 600 ◦C (c,d) for 2 h after the modification with NaOH.
FE-SEM micrographs for such modified TiO2 layers show slight differences in the
surface morphology compared to the non-modified substrates (Figure 1a). Their surfaces
look more roughened than as-prepared ATO layers, though the nanoporous structure of
ATO is not destroyed under any of the applied conditions. The performed EDS analyses
revealed that, apart from Ti and O peaks, the Na peak was present in the spectra (Figure S2).
Besides, the Na content was at the same level for both the non-annealed and annealed
samples [11]. As in the previous case, fluorine was absent in the studied substrates
(Table S2). The above results confirm that the proposed procedure of modification is
effective. Considering the previous studies [25,26], which demonstrated improved drug
release kinetics from the anatase samples, TiO2 layers modified with 0.5 M NaOH for
15 min and annealed at 400 ◦C for 2 h (called Nan) were used for further studies.
2.2. Surface Modifications of Annealed TiO2 Layers with Silane Derivatives
As mentioned, various functional groups on the surface affect ATO layers’ interactions
with drug molecules and cells [16,17]. Therefore, the Nan samples were further modified
with silane derivatives, namely, APTES, GPTMS, and MPTMS. Based on our previous
study [11] on the modification of amorphous ATO layers with silane derivatives, we
applied the same procedure for the annealed NaOH-modified ATO samples. Briefly,
samples were immersed in a 1% APTES, GPTMS, or MPTMS solution for 2 h. Absolute
ethanol was used as a solvent because even a small amount of water may convert silane
derivatives into silanes. Moreover, computer simulations showed that the adsorption of
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water molecules on the TiO2 surface could be competitive with the adsorption of organic
molecules [39].
The silane derivatives are small molecules, and the immersion time is short, so it
can be expected that the samples would be coated with monolayers. Due to this fact, the
elemental composition of ATO surfaces was characterized by using X-ray photoelectron
spectroscopy, and the results are shown in Figure 3 and collected in Table 1.
Figure 3. XPS (X-Ray Photoelectron Spectroscopy) survey spectra of the non-modified (an) and
modified (Nan, Anan, GNan, and MNan) TiO2 samples.
Table 1. Elemental compositions of non-modified (an) and modified (Nan, Anan, GNan, and MNan)
TiO2 samples based on the XPS analyses.
Sample
Atomic Content [%]
C O Ti F Na Si N S
an 11.14 63.70 24.61 0.55 - - - -
Nan 9.12 59.28 19.05 0.72 11.84 - - -
ANan 19.72 50.75 15.85 0.00 4.32 6.29 3.07 -
GNan 19.03 54.49 16.94 0.18 3.89 5.47 - -
MNan 14.57 55.07 17.68 0.44 4.62 4.08 - 3.53
Since XPS is a technique used to analyze the surface chemistry of materials, the differ-
ences in the atomic contents of characteristic elements for the tested samples were observed.
As expected, the fluorine content was low for annealed samples because the heat treat-
ment resulted in removing those anions from the ATO layers. For the non-modified and
NaOH-modified ATO layers, carbon’s presence can be attributed to adventitious carbon
contamination or carbon species embedded in the ATO structure, e.g., during the anodiza-
tion process. In contrast, for the silane-modified samples, higher C content was strictly
related to the modification process. The effectiveness of surface modification was con-
firmed by silicon peaks (Figure 3) in all XPS spectra for silane derivative-modified samples.
It is worth noting that the sodium content decreased considerably after the modification
with silane derivatives (Table 1), which confirms that the surface of titanium dioxide was
covered with other molecules. Additionally, for more in-depth chemical analysis of the
modified TiO2 layers, the detailed XPS spectra for nitrogen, sulfur, silicon, oxygen, and
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carbon are presented in Figures S3–S7, Supplementary Information. Additionally, explana-
tions of the particular signals in each core-level XPS spectra are given there, confirming the
successful modification of ATO substrates with silane derivatives.
One of the factors that significantly affect cell adhesion is the wettability of the bio-
materials [30,35,43] due to the adhesion of water and proteins [4,12]. Their adsorption
occurs immediately after the implant is placed in the patient’s body, so the biomaterial
surface should be hydrophilic [4,12,35,43]. For this reason, the wettability of modified
ATO samples was determined. The average values of the contact angle with the standard
deviation of the mean for n = 20 are presented in Table 2.
Table 2. Contact angle measurements of the non-modified (an) and modified (Nan, Anan, GNan,
and MNan) TiO2 samples.
Sample Contact Angle [◦]
an 41.1 ± 3.3
Nan 14.3 ± 2.2
ANan 20.3 ± 2.7
GNan 18.6 ± 3.9
MNan 29.1 ± 3.0
As shown in Table 2, contact angle values were significantly less than 90◦, proving the
hydrophilic character of the samples. All the annealed substrates were more hydrophilic
than as-prepared amorphous TiO2 layers [11], which is consistent with the literature
data [4,44]. Such behavior may be explained in terms of the increased nano- and micro-
roughness of the annealed surface and the presence of the anatase phase itself [44]. It should
also be pointed out that the hydrophilicity of nanostructured TiO2 also depends on time (the
so-called aging process) [44], storage conditions (e.g., access to air and temperature) [45],
and anodization conditions (e.g., applied voltage, electrolyte composition, and substrate
used) [46]. In the case of the samples used in the present work, only freshly prepared
samples were applied for all the experiments. However, from our laboratory experience,
we observed that annealed and aged samples (even after one year of storage at room
temperature) remained hydrophilic (contact angles were in the range of 40–50◦). This is
also consistent with the work of Shin et al. [44], who showed that for annealed titania
nanotubes formed on the pure Ti foil, the contact angle increased by 15◦ after three months
of the storage.
Further surface modifications led to the enhancement of hydrophilic properties.
Among them, NaOH-modified layers were the most hydrophilic (14.3 ± 2.2). The dif-
ferent wettability levels of the examined samples were caused by their chemical surface
properties caused by various functional groups. The improvement of the TiO2 surface’s
wettability after their immersion in NaOH may be correlated with the presence of hydroxyl
groups. The functionalization with silane derivatives slightly increases the contact angle,
when compared with NaOH-modified samples (29.1 ± 3.0, 20.3 ± 2.7, and 18.6 ± 3.9, for
MPTMS, APTES, and GPTMS, respectively). It is consistent with the observations from
Lin et al. [17], suggesting that the ATO layers with thiol groups at the surface were more
hydrophobic than those with amino groups. Based on the above results, it can be concluded
that all examined samples may exhibit good adsorption of proteins from the medium, and
consequently, sufficient cell adhesion can be expected.
2.3. Effects of the Surface Modification on Ibuprofen Release Kinetics
As presented in our previous studies [11,25,26], drugs with different structures and
water-solubility can be released from TiO2 nanopores. Such a drug delivery process is
described with the desorption-desorption-diffusion (DDD) kinetic model proposed and
described by Jarosz et al. [25]. The DDD model involves the desorption of the drug
molecules from the TiO2 surface, followed by the desorption and diffusion of the molecules
from the nanoporous structure [25]. This model may be applied for both single [25] and
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double-drug release kinetics [26], as well as for the release process from ATO layers with
different crystalline structures [25,26] and surface modification [11].
Figure 4 presents the ibuprofen release profiles according to the DDD kinetic model.
The characteristic parameters describing the process are collected in Table S3. Additionally,
the amounts of ibuprofen released at predetermined time points from the samples are
shown in Table S4, and the cumulative masses of the drug released after 168 h from the
samples are reported in Table S5.
Figure 4. Drug release profiles of ibuprofen from the non-modified (an) and modified (Nan, Anan,
GNan, and MNan) TiO2 samples with the fitted DDD model ((a) an, Nan, and Anan; (b) an, Nan,
and GNan; (c) an, Nan, and MNan; (d) ANan, GNan, and MNan). Insets show the first 2 h of the
release process (the standard deviations of the means, represented as bars, were calculated for n = 3).
As expected, biphasic release behavior was observed for all types of systems (Figure 4).
An initial burst release stage, which occurred immediately after the immersion in the PBS,
was followed by slow ibuprofen delivery [25]. As shown in Table S3, the correlation
coefficients were equal to 0.999, which proved the accuracy of the DDD model fitting.
In contrast to amorphous and functionalized ATO samples [11], no apparent effect of
the surface functionalization on the ibuprofen release process and its kinetic parameters
could be seen (Figure 4 and Table S3). As proved before [25], the presence of the anatase
phase solely caused the significant reduction in the rate of ibuprofen delivery process,
especially the decrease in the amount of drug released during the first stage. When
modified with silane derivatives, only in the case of APTES were differences in the release
kinetics observed, which may be correlated with a significantly lower amount of loaded
ibuprofen for those samples (0.9 mg) than for others (1.9–3.0 mg) (Table S5). Based on the
detailed analysis of kinetic parameters (Table S3), it can be stated that apart from the ANan
samples, the parameters f1 and k1, which describe the first stage of the ibuprofen release
process, take lower values for the modified and annealed TiO2 layers. For all samples,
the parameter f2 was above 0.910, so it can be assumed that the drug release process was
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completed. The parameter k2 (i.e., the first-order kinetic constant for the second stage of
the process) is ascribed to the kinetics of desorption from the inner surface of nanopores.
The values for NaOH-modified and GPTMS-modified samples were higher, while the
values for APTES and MPTMS-modified samples were lower than those for only annealed
titania. The reason for such behavior was the presence of -NH2 and -SH groups, which may
slightly inhibit the process. Moreover, when the dissolution constant (KH) is considered,
only modification with APTES can result in an increase in the diffusion of drug molecules
inside nanopores. As shown in Table S5, for all five types of studied DDSs, the amount of
drug released after a week is similar within the margin of error. Considering the above,
although some differences may be observed, the functionalizations of annealed TiO2 layers
with NaOH and silane derivatives (APTES, GPTMS, and MPTMS) have little or no effect
on the ibuprofen delivery.
2.4. Biocompatibility of the Modified ATO Layers
We recently showed that the modification of amorphous TiO2 layers with NaOH
and APTES improves the interaction between the samples and osteoblast-like cells line
SAOS-2 [11]. In new studies, a cell line with a different phenotype (MG-63) has been
chosen [47]. The MTS test, a one-step colorimetric method, was used to measure the cell
metabolic activity after 2, 24, and 72 h incubations of MG-63 cells on the selected samples.
The results are presented in Figure 5.
The MG-63 cells were incubated on the studied samples to analyze their adhesion,
growth, and proliferation (Figure 5). After 2 h of cultivation, for all surfaces, the cells’
metabolic activity was in the range of 40–80% of the activity of control cells cultivated on
PS (polystyrene) (Figure 5a), which means that the initial cell adhesion to the modified
surfaces was less effective. While the presence of -OH groups at the surface has no impact
on the activity of the cells, significant differences in their metabolism were observed for
the anodic TiO2 layers modified with silane derivatives (Figure 5a). At this point, only
adhesion of cells took place, so its slower rate may have caused the observed differences.
After the 24 h incubation, the cell’s activity reached the PS level, though the statistical
significance was observed only for NaOH and GPTMS modifications (Figure 5b). The
same tendency was noticed for the 72 h cultivation (Figure 5c). Such behavior may be
explained with regard to the wettability of the samples shown earlier, where the highest
hydrophilicity was observed for those two types of modifications. It proves that wettability
plays a crucial role in the adsorption of the molecules and in cell adhesion. Considering
the above, it may be concluded that surface modification with GPTMS affects the adhesion
and proliferation of MG-63 cells the most. Similar improvement in biocompatibility for
such a change has also been observed for the L-929 fibroblasts cell line [48]. Therefore, it
can be assumed that GPTMS-modified ATO layers will be promising in terms of using
titanium-based implants.
The immunofluorescence images and FE-SEM images of MG-63 cells after 24 h of
incubation showing the morphology of adhered cells are presented in Figure 6; those after
2 and 72 h are shown in Figure S8. After 24 h (Figure 6), the cells were well spread on all
samples with clearly marked actin filaments. This is also supported by the FE-SEM images,
where well-flattened cells with clearly visible filopodia may be seen (Figure 6b,d,f,h,j),
which indicates good cell adhesion due to the presence of appropriate adhesive sites [49].
The same observations were reported by Lin et al. [17] for 3T3 fibroblasts on anodic
non-modified and silane derivative-modified TiO2 layers. No significant differences in
the morphology of the MG-63 cells were observed, proving the biocompatibility of the
proposed modified ATO layers.
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Figure 5. Metabolic activity of osteoblast-like cell line MG-63 incubated on the non-modified (an)
and modified (Nan, Anan, GNan, and MNan) TiO2 samples after 2 (a), 24 (b), and 72 (c) hours. The
values are expressed as percentages of the positive control (PS); NS—not statistically significant
differences, *—statistically significant differences at the alpha level of 0.05, #—statistically significant
differences at the alpha level of 0.01, based on ANOVA.
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Figure 6. Representative immunofluorescence and FE-SEM microphotographs of MG-63 osteoblast-
like cells grown on the non-modified (an) (a,b) and modified (Nan, Anan, GNan, and MNan) (c–j)
TiO2 samples, and the control (polystyrene) (k) after 24 h of culture. For fluorescent microscopy
imaging, cells were stained with actin skeleton (green), cell nuclei (blue), and vinculin (red). Scale
bar = 50 µm.
To sum up, it may be stated that all of the proposed samples are biocompatible
and facilitate the adhesion and proliferation of osteoblast-like cells. However, the most
significant changes after 24 and 72 h of incubation may be observed only for the samples
modified with NaOH and GPTMS, proving that surface groups (i.e., -OH and glycidyl)
play essential roles in the interactions between the material and cells.
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3. Materials and Methods
3.1. Synthesis of Nanostructured Titanium Dioxide on Ti Substrate
Rectangular Ti samples with dimensions of 1 cm × 2 cm were first degreased in
acetone and ethanol, and then polished electrochemically (in the mixture of acetic, sul-
furic, and hydrofluoric acids) and chemically (in the mixture of hydrofluoric and nitric
acids) [50]. After being rinsed with distilled water and ethanol, the Ti samples were dried
in the air. Nanoporous TiO2 layers were prepared via a three-step anodization process
in a two-electrode cell with titanium foils as both the anode and cathode. Details re-
garding the standard anodization parameters applied in this work may be found in our
previous papers [51–53]. As a result, the TiO2 films with a suitable pore arrangement
were synthesized.
3.2. Modification of Surface and Crystalline Structure of TiO2 Layers
Two approaches were used to examine how the crystalline structure of TiO2 affects
the surface modification of ATO layers with sodium hydroxide. Firstly, the samples were
annealed at the temperature of 400 or 600 ◦C for 2 h in a muffle furnace (model FCF5-SHM
Z, Czylok, Jastrzębie-Zdrój, Poland) to obtain the anatase and a mixture of anatase and
rutile phases, respectively. After the heat treatment, the TiO2 layers were immersed in
NaOH (0.5 or 1.0 M) for 15 min and rinsed with distilled water. In the second approach,
TiO2 layers were first immersed in sodium hydroxide and then annealed. The morphology
of samples was examined by field emission scanning electron microscopy with energy-
dispersive X-ray spectroscopy (FE-SEM/EDS, Hitachi S-4700 with a Noran System 7,
Krefeld, Germany).
Subsequent surface changes with silane derivatives (APTES, GPTMS, and MPTMS)
were achieved by immersing the NaOH-modified and annealed samples in a 1% ethanolic
solution silane derivatives for 2 h and rinsing with absolute ethanol. The characterization of
the modified nanostructured TiO2 was performed using X-ray photoelectron spectroscopy
(ESCA/XPS) with an Al X-ray source (1486.7 eV) and a semi-spherical analyzer SES R4000
(Gammadata Scienta, Uppsala, Sweden). The maximum energy resolution for the Ag 3d5/2
line was 1.0 eV (for analyzer pass energy of 100 eV). The curves were fitted with a Voigt
profile (GL = 30) and a Shirley background using CasaXPS software 2.3.15.
The contact angle was measured using a sessile drop technique (goniometer Data-
Physics OCA25 equipped with a CCD device and computer, Filderstadt, Germany) to
determine the effect of the surface modification on the wettability of TiO2 layers. The
contact angle was measured 10 times for each deionized water droplet. The procedure was
repeated three times for each type of sample.
3.3. Ibuprofen Delivery Process
An ibuprofen release process from anodic TiO2 layers was examined for selected
samples. A standardized loading strategy described previously was applied [25,26]. Briefly,
1 mL of a 10 wt.% solution of ibuprofen in ethanol (Polfarmex-Kutno, Kutno, Poland) was
pipetted fivefold onto the anodic TiO2 layers, followed by air drying at room temperature.
Afterward, the ibuprofen excess was removed from the surface with the paper towel, and
samples were weighed after a 24 h-storage in a desiccator.
In vitro drug delivery was carried out for a week according to the optimized pro-
cedure [25,26]. The drug-loaded sample was immersed in the 0.01 M phosphate buffer
solution (PBS, pH = 7.4) at a temperature of 37± 1 ◦C. The whole volume of PBS (6 mL) was
replaced with a fresh portion of the solution at predetermined time points. The ibuprofen
concentration was determined based on the UV-Vis spectra recorded at the wavelength
range of 190–300 nm (Thermo Scientific Evolution 220 coupled with Thermo Scientific In-
sight software, Waltham, MA, USA) and then calculated based on the absorbance measure-
ments at 222 nm and constructed calibration curve. The desorption-desorption-diffusion
(DDD) model was fitted to the obtained data to determine the kinetics of the process.
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3.4. Cell Cultivation on Studied ATO Layers
The human osteoblast-like cell line MG-63 (ATCC®CRL-1427, LGS Standards, UK)
was cultivated in DMEM (Dulbecco’s modified eagle’s medium) with glucose, phenol
red, and L-glutamine (Sigma-Aldrich, St. Louis, MI, USA) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (HyClone, Logan, UT, USA), penicillin (10 U mL−1,
HyClone), and streptomycin (10 µg mL−1, HyClone)) at 37 ◦C in a 5% CO2 atmosphere.
The biological experiments were performed for five types of samples: an, Nan, Anan,
GNan, and MNan. Firstly, the samples were exposed to UV light for 15 min in order to
sterilize them. The cells were seeded on ATO layers in 24-well tissue culture plates, and
tissue culture polystyrene (PS) was used as a control. In the biological studies, a seeding
density of 10,000 cells cm−2 was used. The seeded MG-63 cells were incubated for 2, 24,
and 72 h.
3.5. Examination of the Metabolic Activity and Morphology of MG-63 Cells
The CellTiter 96® Aqueous One Solution Cell Proliferation Assay (MTS, Promega,
Madison, WI, USA) was applied to determine the number of viable cells. After 2, 24, or
72 h, the medium was removed, and a 10% MTS solution in the DMEM medium was
added. After the next 2-h incubation at 37 ◦C, 100 µL of 10% MTS solution in DMEM was
transferred into a 96-well plate (in triplicates for each sample). In the end, the absorbance
at 490 nm was measured with a multi-detection micro-plate reader (Epoch™ 2, BioTek,
Winooski, VT, USA). The results were expressed as ratios of absorbance measured for
the TiO2 samples to absorbance of the control (tissue culture PS). The statistical analysis
was based on twelve results for each type of sample obtained from two independent
experiments. The evaluation was carried out using one-way analysis of variance (ANOVA)
(significance assessed at p < 0.05) in R Studio software [54].
The cells were immunofluorescently labeled after the same incubation times to deter-
mine their morphology on the substrates, according to the previously shown procedure [11].
The cells were fixed in 4% paraformaldehyde in PBS for 15 min and then rinsed with PBS.
To increase the cell membranes’ permeability, 0.1% Triton X-100 (Sigma-Aldrich, Poland) in
PBS was added to each well and incubated for 20 min. After that, the cells were rinsed with
PBS, and the blocking solution containing 1% FBS and 0.05% Tween®20 (Sigma-Aldrich,
Poland) in PBS was added to block the non-specific binding sites. After a 30-min incuba-
tion, the solution was replaced with a primary antibody (mouse anti-vinculin monoclonal
antibody) diluted in the blocking solution (1:500, Sigma-Aldrich), and incubated for 1 h at
37 ◦C. Next, the samples were rinsed with PBS. Afterward, secondary antibody, goat anti-
mouse (1:500, Invitrogen, Carlsbad, CA, USA), and phalloidin-Alexa 488 (1:500, Invitrogen)
in a blocking solution, were added and incubated at 37 ◦C for 45 min. After the rinse with
PBS, the cell nuclei were labeled with 4′,6-diamidino-2-phenylindole dihydrochloride in
PBS (DAPI, 1:1000, Sigma-Aldrich, Poland) and incubated for 15 min. In the end, the ATO
layers were rinsed with PBS and mounted with a mounting medium (Thermo Scientific™
Shandon™ Immu-Mount™, Thermo Scientific). Fluorescence images of the stained MG-63
cells were obtained with the Olympus IX51 (Olympus, Warsaw, Poland) equipped with an
XC10 camera.
Additionally, the morphology of the studied samples was examined by using the
scanning electron microscope. ATO layers were firstly fixed with a 3% glutaraldehyde
solution for 24 h. The samples were then rinsed three times with PBS and dehydrated in
the alcohol series (the ethanol solutions with a concentration of 50%, 60%, 70%, 80%, 90%,
96%, and 100%). Non-modified and modified TiO2 were placed in each solution for 15 min.
Finally, the substrates were dried for 1 min in the solution of hexamethyldisilazane [55].
Before the samples were characterized with SEM, they were coated with a 15-nm layer of
gold using a sputter coater (Quorum Q150T S, UK).
Molecules 2021, 26, 1723 13 of 16
4. Conclusions
This report has shown how structural and surface modifications of nanostructured
TiO2 influence the biocompatibility and drug release properties.
It was found that anatase and mixed anatase and rutile phases could not be effectively
modified with NaOH, whereas a crystalline structure change is possible for the NaOH-
modified samples. Therefore, for effective and nondestructive modification, the sequence
of the modification steps is crucial. Moreover, such samples may be further functionalized
with silane derivatives having different functional groups. Both the heat treatment and
surface functionalization improved the hydrophilicity of the studied ATO surfaces, which
are crucial for biomedical applications.
Modified ATO layers were used to test the ibuprofen release from the nanopores.
Unfortunately, the additional modifiers did not affect the release kinetics in any way. The
most significant improvement was observed only for the annealed layers. On the other
hand, the proposed modifications improved the cell responses on the studied substrates.
The biological studies showed an increase in the metabolic activity of MG-63 cells and
improvement in the cells’ morphology, especially when samples were modified with APTES
and GPTMS.
To summarize, the presented data provide more information about the surface modifi-
cation of nanostructured anatase layers. It can also be postulated that the modifications
with APTES and GPTMS were the most beneficial for the potential implantable materials,
which improve cell response and provide drug molecules directly at the implantation site.
Supplementary Materials: Figure S1: EDS spectra of nanoporous TiO2 layers annealed at 400 ◦C
for 2 h and then immersed in 0.5 M (a) or 1.0 M (b) NaOH for 15 min. The Au peak in the spectra
has arisen from a gold layer sputtered before SEM examination. Table S1: Elemental compositions
(Ti, O, Na, and F) of TiO2 samples annealed at 400 ◦C for 2 h and then immersed in 0.5 or 1.0 M
NaOH for 15 min, calculated based on EDS spectra. Figure S2: EDS spectra of nanoporous TiO2
layers modified with 0.5 M (a) or 1.0 M (b) NaOH for 15 min and then annealed at 400 ◦C for 2 h.
The Au peak in the spectra has arisen from a gold layer sputtered before SEM examination. Table S2:
Elemental composition (Ti, O, Na, and F) of TiO2 samples modified with 0.5 M or 1.0 M NaOH for
15 min and then annealed at 400 ◦C for 2 h, calculated based on EDS spectra. Figure S3: Core-level
XPS spectra of N 1s for the ANan sample. Figure S4: Core-level XPS spectra of S 2p for the MNan
sample. Figure S5: Core-level XPS spectra of Si 2p for the ANan (a), GNan (b), and MNan (c) samples.
Figure S6: Core-level XPS spectra of O 1s for the an (a), Nan (b), ANan (c), GNan (d), and MNan (e)
samples. Figure S7: Core-level XPS spectra of C 1s for the an (a), Nan (b), ANan (c), GNan (d), and
MNan (e) samples. Table S3: The desorption-desorption-diffusion model parameters (f1, f2, k1, k2,
KH) with parameter standard errors for the ibuprofen release from the modified and non-modified
annealed TiO2 layers. Table S4: The amounts of ibuprofen released after pre-determined time points,
namely, 10 s, 60 s, 10 min, 30 min, 1 h, 2 h, 24 h, and 168 h, from the modified and non-modified
annealed TiO2 layers. Table S5: The amounts of ibuprofen loaded inside nanoporous TiO2 layers
and released after 168 h from the modified and non-modified annealed TiO2 samples (with standard
deviation, n = 3). Figure S8: Representative immunofluorescence images of MG-63 osteoblast-like
cells grown on the an (anatase TiO2) (a,b), Nan (amorphous TiO2 + NaOH + 400 ◦C) (c,d), ANan
(amorphous TiO2 + NaOH + 400 ◦C + APTES) (e,f), GNan (amorphous TiO2 + NaOH + 400 ◦C +
GPTMS) (g,h), MNan (amorphous TiO2 + NaOH + 400 ◦C + MPTMS) (i,j), and control (polystyrene)
(k,l) samples after 2 and 72 h of culture. Cells were stained with actin skeleton (green), cell nuclei
(blue), and vinculin (red). Scale bar = 50 µm.
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